Glaxosmithkline Biologicals
Glaxosmithkline Biologicals is a Public Limited Company registered in Belgium under 0440872918, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 1 July 1990 and lists its registered address as Belgium. 3 shareholders are on record for Glaxosmithkline Biologicals, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 15 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Three shareholders are currently on record for Glaxosmithkline Biologicals, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing.
The largest of these is SETFIRST LIMITED S. Etr., holding 56.6% — a majority holding — followed by SETFIRST LIMITED S. Etr. at 23%; the remaining 1 shareholder shown holds smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| SETFIRST LIMITED S. Etr. | 56.6% | Crossroads Bank for Enterprises (KBO/BCE) | |
| SETFIRST LIMITED S. Etr. | 23% | Crossroads Bank for Enterprises (KBO/BCE) | |
| GLAXOSMITHKLINE LLC S. Etr | 20.4% | Crossroads Bank for Enterprises (KBO/BCE) |
Officers
5
The Director of Glaxosmithkline Biologicals on record is Pascal Legraive; 5 officers are shown here, filed with Crossroads Bank for Enterprises (KBO/BCE).
The register reports 40 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Glaxosmithkline Biologicals sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Glaxosmithkline Biologicals sits 4 levels below its ultimate parent, GSK PLC, registered in United Kingdom. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. The full chain up to GSK PLC is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Glaxosmithkline Biologicals's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span Belgium, France, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
GSK PLC
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Glaxosmithkline Biologicals?
Three shareholders are currently on record for Glaxosmithkline Biologicals, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is SETFIRST LIMITED S. Etr., holding 56.6% — a majority holding — followed by SETFIRST LIMITED S. Etr. at 23%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Glaxosmithkline Biologicals's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Glaxosmithkline Biologicals is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Glaxosmithkline Biologicals have on record?
3 shareholders are shown on record for Glaxosmithkline Biologicals.
What is Glaxosmithkline Biologicals's company registration number?
Glaxosmithkline Biologicals's registration number is 0440872918, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.
Is Glaxosmithkline Biologicals still an active company?
Glaxosmithkline Biologicals's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.
When was Glaxosmithkline Biologicals incorporated?
Glaxosmithkline Biologicals was incorporated on 1 July 1990, according to Crossroads Bank for Enterprises (KBO/BCE).
What is Glaxosmithkline Biologicals's registered address?
The registered address on file for Glaxosmithkline Biologicals is Belgium.
What legal structure is Glaxosmithkline Biologicals registered as?
Glaxosmithkline Biologicals is registered as a Public Limited Company in Belgium.
Who are the officers/directors of Glaxosmithkline Biologicals?
The Director of Glaxosmithkline Biologicals on record is Pascal Legraive; 5 officers are shown here, filed with Crossroads Bank for Enterprises (KBO/BCE). Management authority at Glaxosmithkline Biologicals sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Glaxosmithkline Biologicals have a parent company or subsidiaries?
Glaxosmithkline Biologicals sits 4 levels below its ultimate parent, GSK PLC, registered in United Kingdom. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. Those 2 subsidiaries span Belgium, France, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Glaxosmithkline Biologicals's ownership over time?
This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Glaxosmithkline Biologicals's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Glaxosmithkline Biologicals's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Glaxosmithkline Biologicals's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 15 September 2026.